302 related articles for article (PubMed ID: 32482678)
1. AR-12 Exhibits Direct and Host-Targeted Antibacterial Activity toward
Zhang S; Zou Y; Guo Q; Chen J; Xu L; Wan X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32482678
[TBL] [Abstract][Full Text] [Related]
2. A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity
Wu W; He S; Li A; Guo Q; Tan Z; Liu S; Wang X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0060122. PubMed ID: 35969055
[TBL] [Abstract][Full Text] [Related]
3.
Cheng A; Tsai YT; Chang SY; Sun HY; Wu UI; Sheng WH; Chen YC; Chang SC
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670428
[TBL] [Abstract][Full Text] [Related]
4.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
[TBL] [Abstract][Full Text] [Related]
5. Activity of Oritavancin and Its Synergy with Other Antibiotics against
Wang G; Tang J; Feng J; Dong W; Huo X; Lu H; Wang C; Lu W; Wang X; Chen H; Tan C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198513
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
Portell-Buj E; Bonet-Rossinyol Q; López-Gavín A; Roman A; Fernández-Pittol M; Tudó G; Gonzalez-Martin J
J Antibiot (Tokyo); 2021 Apr; 74(4):285-290. PubMed ID: 33420382
[TBL] [Abstract][Full Text] [Related]
7.
Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
[TBL] [Abstract][Full Text] [Related]
8. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
Pryjma M; Burian J; Thompson CJ
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
[No Abstract] [Full Text] [Related]
9. Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the
Pryjma M; Burian J; Kuchinski K; Thompson CJ
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874379
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419
[TBL] [Abstract][Full Text] [Related]
11. [The analysis of species identification and susceptibility testing of Mycobacterium abscessus].
Nie W; Duan H; Huang H; Lu Y; Chu N
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jul; 37(7):517-21. PubMed ID: 25262693
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the intracellular activity of drugs against Mycobacterium abscessus using a THP-1 macrophage model.
Molina-Torres CA; Tamez-Peña L; Castro-Garza J; Ocampo-Candiani J; Vera-Cabrera L
J Microbiol Methods; 2018 May; 148():29-32. PubMed ID: 29626567
[TBL] [Abstract][Full Text] [Related]
13. Potency of Omadacycline against Mycobacteroides abscessus Clinical Isolates
Nicklas DA; Maggioncalda EC; Story-Roller E; Eichelman B; Tabor C; Serio AW; Keepers TR; Chitra S; Lamichhane G
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0170421. PubMed ID: 34662184
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense.
Zhang Z; Lu J; Liu M; Wang Y; Zhao Y; Pang Y
Int J Antimicrob Agents; 2017 Mar; 49(3):383-386. PubMed ID: 28188830
[TBL] [Abstract][Full Text] [Related]
15. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
[TBL] [Abstract][Full Text] [Related]
16. Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in
Ruth MM; van Rossum M; Koeken VACM; Pennings LJ; Svensson EM; Ruesen C; Bowles EC; Wertheim HFL; Hoefsloot W; van Ingen J
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262763
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Lee MC; Sun PL; Wu TL; Wang LH; Yang CH; Chung WH; Kuo AJ; Liu TP; Lu JJ; Chiu CH; Lai HC; Chen NY; Yang JH; Wu TS
J Antimicrob Chemother; 2017 Oct; 72(10):2782-2786. PubMed ID: 29091186
[TBL] [Abstract][Full Text] [Related]
18. Sudapyridine (WX-081) antibacterial activity against
Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial susceptibility profiles of Mycobacterium abscessus complex isolates from respiratory specimens in Shanghai, China.
Guo Q; Wei J; Zou W; Li Q; Qian X; Zhu Z
J Glob Antimicrob Resist; 2021 Jun; 25():72-76. PubMed ID: 33689828
[TBL] [Abstract][Full Text] [Related]
20. Analysis of drug-susceptibility patterns and gene sequences associated with clarithromycin and amikacin resistance in serial Mycobacterium abscessus isolates from clinical specimens from Northeast Thailand.
Ananta P; Kham-Ngam I; Chetchotisakd P; Chaimanee P; Reechaipichitkul W; Namwat W; Lulitanond V; Faksri K
PLoS One; 2018; 13(11):e0208053. PubMed ID: 30496270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
